Clinical Trial Update: A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1 [Phase 2]

View source ↗

Summary

Phase 2 open-label trial evaluating safety and effects of HLX-1502 in patients with Neurofibromatosis Type 1 is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Drugs mentioned

• HLX-1502

Snippet

Sponsor: Healx Limited | Conditions: Neurofibromatosis Type 1 | Phase 2 | Status: RECRUITING